Modulation of experimental autoimmune encephalomyelitis by endogenous Annexin A1

Journal of Neuroinflammation

Volumn 6, Issue , 2009, Pages

  Paschalidis, Nikolaos ^a   Iqbal, Asif J ^a   Maione, Francesco ^a   Wood, Elisabeth G ^a   Perretti, Mauro ^a   Flower, Rod J ^a   D'Acquisto, Fulvio ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOCORTIN 1; CYTOKINE; GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35 55); MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55); PEPTIDE FRAGMENT;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IN VITRO STUDY; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PROTEIN FUNCTION; SPINAL CORD; T LYMPHOCYTE; TH1 CELL; WILD TYPE; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; CHEMICALLY INDUCED DISORDER; CYTOLOGY; IMMUNOLOGY; LYMPH NODE; LYMPHOCYTE SUBPOPULATION; METABOLISM; MOUSE MUTANT; PATHOLOGY;

ANIMALS; ANNEXIN A1; CELL PROLIFERATION; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GLYCOPROTEINS; LYMPH NODES; LYMPHOCYTE SUBSETS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; SPINAL CORD; TH1 CELLS;

EID: 71049131229     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-6-33     Document Type: Article

References (36)

1. Fugger L, Friese MA, Bell JI. From genes to function: the next challenge to understanding multiple sclerosis. Nat Rev Immunol 2009, 9(6):408-17. 19444306, 10.1038/nri2554.
2. Goverman J. Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 2009, 9(6):393-407. 19444307, 10.1038/nri2550.
3. Murphy KM, Reiner SL. The lineage decisions of helper T cells. Nat Rev Immunol 2002, 2:933-944. 12461566, 10.1038/nri954.
4. Martinez GJ, Nurieva RI, Yang XO, Dong C. Regulation and function of proinflammatory TH17 cells. Ann N Y Acad Sci 2008, 1143:188-211. 19076351, 10.1196/annals.1443.021.
5. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006, 24:677-688. 16782025, 10.1016/j.immuni.2006.06.002.
6. Parente L, Solito E. Annexin 1: more than an anti-phospholipase protein. Inflamm Res 2004, 53:125-132. 15060718, 10.1007/s00011-003-1235-z.
7. Blackwell GJ, Carnuccio R, Di Rosa M, Flower RJ, Parente L, Persico P. Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature 1980, 287:147-149. 6893620, 10.1038/287147a0.
8. Perretti M, D'Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol 2009, 9:62-70. 19104500, 10.1038/nri2470.
9. D'Acquisto F, Perretti M, Flower RJ. Annexin-A1: a pivotal regulator of the innate and adaptive immune systems. Br J Pharmacol 2008, 155:152-169. 18641677, 10.1038/bjp.2008.252, 2538690.
10. D'Acquisto F. On the adaptive nature of Annexin-A1. Curr Opin Pharmacol 2009, 9:521-528. 19481503, 10.1016/j.coph.2009.04.007.
11. D'Acquisto F, Merghani A, Lecona E, Rosignoli G, Raza K, Buckley CD, Flower RJ, Perretti M. Annexin-1 modulates T-cell activation and differentiation. Blood 2007, 109:1095-1102. 17008549, 10.1182/blood-2006-05-022798, 1855438.
12. D'Acquisto F, Paschalidis N, Sampaio A, Merghani A, Flower RJ, Perretti M. Impaired t cell activation and increased T helper 2 lineage commitment in Annexin-1 deficient T cells. Eur J Immunol
13. D'Acquisto F, Paschalidis N, Raza K, Buckley CD, Flower RJ, Perretti M. Glucocorticoid treatment inhibits annexin-1 expression in rheumatoid arthritis CD4+ T cells. Rheumatology (Oxford) 2008, 47:636-639. 18390587, 10.1093/rheumatology/ken062.
14. Hannon R, Croxtall JD, Getting SJ, Roviezzo F, Yona S, Paul-Clark MJ, Gavins FN, Perretti M, Morris JF, Buckingham JC, Flower RJ. Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse. Faseb J 2003, 17:253-255.
15. Roviezzo F, Getting SJ, Paul-Clark MJ, Yona S, Gavins FN, Perretti M, Hannon R, Croxtall JD, Buckingham JC, Flower RJ. The annexin-1 knockout mouse: what it tells us about the inflammatory response. J Physiol Pharmacol 2002, 53:541-553.
16. Elderfield AJ, Bolton C, Flower RJ. Lipocortin 1 (annexin 1) immunoreactivity in the cervical spinal cord of Lewis rats with acute experimental allergic encephalomyelitis. J Neurol Sci 1993, 119:146-153. 8277328, 10.1016/0022-510X(93)90127-K.
17. Iglesias A, Bauer J, Litzenburger T, Schubart A, Linington C. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 2001, 36:220-234. 11596130, 10.1002/glia.1111.
18. Damazo AS, Yona S, D'Acquisto F, Flower RJ, Oliani SM, Perretti M. Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation. Am J Pathol 2005, 166:1607-1617. 1602430, 15920146.
19. D'Acquisto F, Paschalidis N, Sampaio AL, Merghani A, Flower RJ, Perretti M. Impaired T cell activation and increased Th2 lineage commitment in Annexin-1-deficient T cells. Eur J Immunol 2007, 37:3131-3142. 17948261, 10.1002/eji.200636792.
20. Kennedy MK, Torrance DS, Picha KS, Mohler KM. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 1992, 149:2496-2505.
21. Khoury SJ, Hancock WW, Weiner HL. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 1992, 176:1355-1364. 1383385, 10.1084/jem.176.5.1355, 2119419.
22. Steinman L. A rush to judgment on Th17. J Exp Med 2008, 205:1517-1522. 18591407, 10.1084/jem.20072066, 2442627.
23. Panitch HS, Hirsch RL, Haley AS, Johnson KP. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987, 1:893-895. 2882294, 10.1016/S0140-6736(87)92863-7.
24. Segal BM, Shevach EM. IL-12 unmasks latent autoimmune disease in resistant mice. J Exp Med 1996, 184:771-775. 8786337, 10.1084/jem.184.2.771, 2192714.
25. Baron JL, Madri JA, Ruddle NH, Hashim G, Janeway CA. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 1993, 177:57-68. 7678116, 10.1084/jem.177.1.57, 2190872.
26. Gran B, Zhang GX, Yu S, Li J, Chen XH, Ventura ES, Kamoun M, Rostami A. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J Immunol 2002, 169:7104-7110.
27. Ferber IA, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, Steinman L, Dalton D, Fathman CG. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 1996, 156:5-7.
28. Kassiotis G, Kollias G. TNF and receptors in organ-specific autoimmune disease: multi-layered functioning mirrored in animal models. J Clin Invest 2001, 107:1507-1508. 11413157, 10.1172/JCI13362, 200203.
29. Kassiotis G, Kollias G. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J Exp Med 2001, 193:427-434. 11181695, 10.1084/jem.193.4.427, 2195909.
30. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Langer-Gould A, Strober S, Cannella B, Allard J. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 2002, 8:500-508. 11984595, 10.1038/nm0502-500.
31. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240. 15657292, 10.1084/jem.20041257, 2212798.
32. Haak S, Croxford AL, Kreymborg K, Heppner FL, Pouly S, Becher B, Waisman A. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J Clin Invest 2009, 119:61-69. 2613466, 19075395.
33. Friese MA, Montalban X, Willcox N, Bell JI, Martin R, Fugger L. The value of animal models for drug development in multiple sclerosis. Brain 2006, 129:1940-1952. 16636022, 10.1093/brain/awl083.
34. Huitinga I, Bauer J, Strijbos PJ, Rothwell NJ, Dijkstra CD, Tilders FJ. Effect of annexin-1 on experimental autoimmune encephalomyelitis (EAE) in the rat. Clin Exp Immunol 1998, 111:198-204. 9472682, 10.1046/j.1365-2249.1998.00490.x, 1904852.
35. Bolton C, Elderfield AJ, Flower RJ. The detection of lipocortins 1, 2 and 5 in central nervous system tissues from Lewis rats with acute experimental allergic encephalomyelitis. J Neuroimmunol 1990, 29:173-181. 2145319, 10.1016/0165-5728(90)90160-O.
36. Elderfield AJ, Newcombe J, Bolton C, Flower RJ. Lipocortins (annexins) 1, 2, 4 and 5 are increased in the central nervous system in multiple sclerosis. J Neuroimmunol 1992, 39:91-100. 1535635, 10.1016/0165-5728(92)90178-N.